First Description of Novel End-Organ Effects by Speed Modulation Using the Aortix™ Device
Table 1
Laboratory and hemodynamic data during the patient’s hospital course as it relates to pre-Aortix™ device implantation, during implantation, and after device removal. Refer to Figure 3 for graphic representation.
Time from Aortix™ device implantation (hours)
Aortix™ device speed (×1,000 rpm)
Serum creatinine (mg/dL)
Serum BUN (mg/dL)
Serum AST (U/L)
Serum ALT (U/L)
Right atrial pressure (mmHg)
Pulmonary capillary wedge pressure (mmHg)
Pre-device implantation
N/A
1.5
54
92
178
18
33
9
25
2.3
63
1450
1074
18
23
12
25
2.4
68
2125
1381
19
23
23
25
2.8
67
2519
1854
23
29
35
25
3.2
69
3396
2740
14
21
42
22
2.9
76
3286
2978
10
19
46
20
2.7
64
2702
2773
9
16
59
24
2.0
55
1768
2364
5
16
70
25
1.4
46
1768
1966
10
22
82
25
1.3
50
861
1632
9
20
96
25
1.4
43
698
1466
7
15
Post-device removal
N/A
1.1
40
499
1227
14
24
119
N/A
0.9
35
413
1143
15
20
129
N/A
1
35
326
937
251
N/A
1.3
43
61
256
AST = aspartate aminotransferase; ALT = alanine aminotransferase; BUN = blood urea nitrogen; rpm = rotations per minute.
